Avita Medical | 1811094D - Ebit

Stock Price
1.22
Daily Change
-0.01 -0.41%
Monthly
9.46%
Yearly
-58.81%
Q1 Forecast
1.19

Avita Medical reported AUD-8.66M in EBIT for its fiscal semester ending in June of 2025.





Ebit Change Date
Celltrion KRW 301.04B 58.57B Sep/2025
Clinuvel Pharmaceuticals AUD 32.21M 14.41M Jun/2024
Cochlear AUD 275M 25.5M Dec/2024
CSL USD 2.75B 1.35B Dec/2024
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Divis Laboratories Ltd INR 7.75B 1.58B Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 300K Dec/2024
Mayne Pharma AUD -16.2M 13.2M Jun/2024
Medical Developments International AUD -12.12M 3.97M Jun/2023
Nanosonics AUD 8.7M 2.6M Dec/2024
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -19.93M 12.02M Jun/2023
Pharma Mar EUR -3.96M 28.11M Sep/2025
Polynovo AUD 840K 147K Jun/2024
PYC Therapeutics AUD -25.84M 3M Dec/2024
Qiagen NV USD 141.06M 6.64M Sep/2025
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
ResMed USD 497.6M 35.25M Dec/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Telix Pharmaceuticals AUD 37.44M 16.38M Dec/2024
Tilray USD -20.01M 9.34M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 15.6M Sep/2025